CorMedix Inc (CRMD) is looking forward to a strong quarter

With 4.18 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.46 million shares. The 52-week range on CRMD shows that it touched its highest point at $13.85 and its lowest point at $3.61 during that stretch. It currently has a 1-year price target of $16.33. Beta for the stock currently stands at 1.55.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CRMD was up-trending over the past week, with a rise of 22.37%, but this was up by 90.44% over a month. Three-month performance surged to 6.49% while six-month performance rose 10.99%. The stock gained 107.82% in the past year, while it has gained 37.78% so far this year. A look at the trailing 12-month EPS for CRMD yields 0.23 with Next year EPS estimates of 1.45. For the next quarter, that number is 0.12. This implies an EPS growth rate of 338.33% for this year and 102.80% for next year.

Float and Shares Shorts:

At present, 65.18 million CRMD shares are outstanding with a float of 59.59 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CRMD since 2 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 1 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.3312 being high and -$0.45011 being low. For CRMD, this leads to a yearly average estimate of -$0.38429.